NewHOPE

NewHOPE offers a unique platform of human organoids and cell models, combined with clinical data, to accelerate research and the development of new therapies.

What we provide

NewHOPE offers researchers access to high-quality human cell and organoid models across lung, gastrointestinal, kidney, and urinary tissues. Our integrated biobank combines these samples with rich clinical data, including immune profiles, microbiome, genetics, diet, and medications, creating a unique platform for studying human biology and disease.

Our platform

Designed for precision and reproducibility, we collect and processes samples using a process-driven approach. This ensures researchers receive the most relevant and high-quality data to explore disease mechanisms, support preclinical studies, and test novel therapies.

Governance and standards

An Executive Committee oversees NewHOPE. This ensures it remains innovative, sustainable, and aligned with the needs of clinical, academic, and industry partners. Activities are conducted under ethical approval from the Hunter New England Human Research Ethics Committee. Activities follow best-practice biobanking and organoid generation standards.